Clinical Trials Browser

Phase 2/3 × Non-Muscle Invasive Bladder Neoplasms × Clear all

NCT03022825 2025-10-16

QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer

Phase 2/3 Active not recruiting

190 enrolled 1 FDA

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT07198451 2025-09-30

GEM-IR-NMIBC

Phase 2/3 Not yet recruiting

Non-Muscle Invasive Bladder Neoplasms, Recurrence

NCT01475266 2017-03-29

Single Immediate Instillation of EO9 After TURBT in Patients With Non-muscle-invasive Bladder Cancer (NMIBC)

Phase 2/3 Terminated

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT01920269 2013-08-09

EMDA/MMC

Phase 2/3 Completed

Non-Muscle Invasive Bladder Neoplasms

NCT00330707 2011-03-04

Combined Use of BCG and Interferon Alpha in Bladder Cancer

Phase 2/3 Completed

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT00816075 2009-02-17

Efficacy of Distilled Water Versus Mitomycin C on Preventing Recurrences of Bladder Cancer After Transurethral Resection

Phase 2/3 Unknown

Non-Muscle Invasive Bladder Neoplasms, Recurrence